PhRMA Welcomes 2018 Special 301 Report - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
April 28, 2018 Newswires
Share
Share
Post
Email

PhRMA Welcomes 2018 Special 301 Report

Targeted News Service (Press Releases)

WASHINGTON, April 27 -- The Pharmaceutical Research and Manufacturers of America issued the following news release:

The Pharmaceutical Research and Manufacturers of America (PhRMA) welcomed the 2018 Special 301 Report, including a new section devoted to pharmaceutical market access barriers, released today by U.S. Trade Representative (USTR) Robert Lighthizer. The Report highlights serious threats America's biopharmaceutical innovators face in countries around the world, including with trading partners like Canada, Japan, Colombia and others.

"America leads the world in the research and development of new medicines, but some foreign countries stack the deck against our companies," said Stephen J. Ubl, president and CEO of PhRMA. "Discriminatory pricing and reimbursement policies in Canada, Korea and Japan put our jobs and exports at risk. America needs to fight back - which is why we are encouraged the Trump Administration is taking on foreign governments. The U.S. government should continue using all available tools, including ongoing NAFTA negotiations, to level the playing field for American innovators. A fair and competitive marketplace will drive down costs for U.S. patients."

PhRMA's Special 301 submission asked USTR to name Korea, Canada and Malaysia Priority Foreign Countries, a designation reserved for economies with the most onerous and egregious intellectual property or market access practices that have the greatest impact on U.S. products. Earlier this year, USTR secured a commitment under the U.S.-Korea Free Trade Agreement (KORUS) that Korea will end some discriminatory pricing and reimbursement policies. USTR today downgraded Canada from the Watch List to the Priority Watch List and committed to an Out-of-Cycle review of Malaysia's intellectual property system.

The USTR report also places a priority on solving longstanding problems in India, Indonesia, Chile and other countries, and heading off emerging threats in Colombia and Saudi Arabia.

"We look forward to continuing to work with the Trump Administration to address intellectual property and market access barriers that limit patient access to new treatments and cures," Ubl added.

There has never been a more important time to protect and value American innovation. Innovative biopharmaceutical companies in the United States invest $90 billion annually in research and development to find tomorrow's cures for diseases like cancer and Alzheimer's. With about 4,000 medicines in development, open markets and strong intellectual property protections abroad are more critical than ever.

Required by the Trade Act of 1974, the annual Special 301 Report identifies foreign countries that deny adequate and effective intellectual property protection or fair and equitable market access for U.S. products. The detailed information presented in PhRMA's Special 301 submission highlighted damaging practices that deny adequate and effective intellectual property protection or fair and equitable market access in 20 overseas markets.

View PhRMA's complete 2018 Special 301 Submission here (http://www.phrma.org/policy-paper/phrma-special-301-submission-2018) and an infographic on the issue here (https://www.phrma.org/graphic/foreign-threats-to-american-intellectual-property).

Older

Rep. Larson: CT House Delegation Requests Gov. Malloy’s Assistance to Protect Residents From Trump Administration’s Healthcare Policies

Newer

Company Will Plant 80,000 Trees Across Four States With Arbor Day Foundation

Advisor News

  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
  • Semi-retirement: helping clients balance flexibility with financial security
  • The 6X Formula for leveraging content marketing with AI
  • When a home becomes difficult to insure, the plan changes
More Advisor News

Annuity News

  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Global Atlantic launches ForeIncome Flex
  • Athene CEO criticizes offshore reinsurance, risk-taking by competitors
  • DOL, trade groups, state AGs file briefs supporting Alcoa in PRT lawsuit
  • John Hancock launches new fixed indexed annuity suite
More Annuity News

Health/Employee Benefits News

  • High costs inhibit Nebraskans from seeking healthcare, poll shows
  • Franklin County Hiring Juvenile Probation Officer
  • Soaring drug costs squeeze largest Mass. insurer, fueling $43.5M loss
  • Health insurers leave Ohio marketplace
  • Rising hospital, drug costs boost health insurance premiums at fastest pace since start of Obamacare
More Health/Employee Benefits News

Life Insurance News

  • Navigating delayed death certificates: A guide for life insurance advisors
  • Jackson Launches Direct-to-Consumer Annuity Offering
  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on New Zealand’s Non-Life Insurance Segment
  • AM Best Affirms Credit Ratings of Fubon Insurance Vietnam Co., Ltd.
  • Three lawsuits put life insurers’ cost-of-insurance practices under scrutiny
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
  • Lauren Sinnott Named to Ragan’s Top Women in Marketing Awards, Class of 2026 
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.